We constructed a transcutaneous bilirubin (TcB) nomogram to represent major sectors of the Israeli population. We studied the risk of hyperbilirubinemia, defined as meeting the requirements for phototherapy, per percentile risk category.
Newborns ⩾36 weeks gestation were tested daily for TcB, using Drager JM-103 devices, during birth hospitalization. A nomogram was constructed and divided into four risk groups and validated by calculating the need for phototherapy for each group.
A total of 3303 measurements were performed on 1059 consecutive newborns including Ashkenazi, Sephardic and mixed Ashkenazi/Sephardic Jews, Arab and Ethiopian Jewish. Phototherapy risk increased progressively and more than 100-fold, from 0/225 in the <40th percentile group through 27/120 (22.5%) for those >95th percentile (relative risk (95% confidence interval) 102 (6 to 1669) for those >95th percentile compared with those <40th percentile). The optimal risk for discriminating the need for phototherapy was >75th percentile (sensitivity 93.33, specificity 59.47).
The risk of significant hyperbilirubinemia increased progressively with increasing percentile. Newborns >75th percentile groups are at high risk for phototherapy and should be closely monitored.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Riskin A, Tamir A, Kugelman A, Hemo M, Bader D . Is visual assessment of jaundice reliable as a screening tool to detect significant neonatal hyperbilirubinemia? J Pediatr 2008; 152: 782–787.
Bhutani VK, Johnson L, Sivieri EM . Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999; 103: 6–14.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297–316.
Maisels MJ, Kring E . Transcutaneous bilirubin levels in the first 96 h in a normal newborn population of>or=35 weeks' gestation. Pediatrics 2006; 117: 1169–1173.
Fouzas S, Mantagou L, Skylogianni E, Mantagos S, Varvarigou A . Transcutaneous bilirubin levels for the first 120 postnatal hours in healthy neonates. Pediatrics 2010; 125: e52–e57.
Akahira-Azuma M, Yonemoto N, Mori R, Hosokawa S, Matsushita T, Sukhbat K et al. An hour-specific transcutaneous bilirubin nomogram for Mongolian neonates. Eur J Pediatr 2015; 174: 1299–1304.
Kuboi T, Kusaka T, Kawada K, Koyano K, Nakamura S, Okubo K et al. Hour-specific nomogram for transcutaneous bilirubin in Japanese neonates. Pediatr Int 2013; 55: 608–611.
Han S, Yu Z, Liu L, Wang J, Wei Q, Jiang C et alChinese Multicenter Study Coordination Group for Neonatal Hyperbilirubinemia. A model for predicting significant hyperbilirubinemia in neonates from China. Pediatrics 2015; 136: e896–e905.
Engle WD, Lai S, Ahmad N, Manning MD, Jackson GL . An hour-specific nomogram for transcutaneous bilirubin values in term and late preterm Hispanic neonates. Am J Perinatol 2009; 26: 425–430.
Yu ZB, Dong XY, Han SP, Chen YL, Qiu YF, Sha L et al. Transcutaneous bilirubin nomogram for predicting neonatal hyperbilirubinemia in healthy term and late-preterm Chinese infants. Eur J Pediatr 2011; 170: 185–191.
Draque CM, Sañudo A, de Araujo Peres C, de Almeida MF . Transcutaneous bilirubin in exclusively breastfed healthy term newborns up to 12 days of life. Pediatrics 2011; 128: e565–e571.
De Luca D, Romagnoli C, Tiberi E, Zuppa AA, Zecca E . Skin bilirubin nomogram for the first 96 h of life in a European normal healthy newborn population, obtained with multiwavelength transcutaneous bilirubinometry. Acta Paediatr 2008; 97: 146–150.
Bental YA, Shiff Y, Dorsht N, Litig E, Tuval L, Mimouni FB . Bhutani-based nomograms for the prediction of significant hyperbilirubinaemia using transcutaneous measurements of bilirubin. Acta Paediatr 2009; 98: 1902–1908.
Abu Omar R, Algur N, Megged O, Hammerman C, Kaplan M . Glucose-6-phosphate dehydrogenase screening in Israel-Arab and Palestinian-Arab neonates. J Pediatr 2015; 167: 169–172.
Kaplan M, Merlob P, Regev R . Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. J Perinatol 2008; 28: 389–397.
Maisels MJ, Deridder JM, Kring EA, Balasubramaniam M . Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. J Perinatol 2009; 29: 612–617.
Mohamed I, Blanchard AC, Delvin E, Cousineau J, Carceller A . Plotting transcutaneous bilirubin measurements on specific transcutaneous nomogram results in better prediction of significant hyperbilirubinemia in healthy term and near-term newborns: a pilot study. Neonatology 2014; 105: 306–311.
Romagnoli C, Tiberi E, Barone G, De Curtis M, Regoli D, Paolillo P et al. Validation of transcutaneous bilirubin nomogram in identifying neonates not at risk of hyperbilirubinaemia: a prospective, observational, multicenter study. Early Hum Dev 2012; 88: 51–55.
Kaplan M, Bromiker R, Hammerman C . Hyperbilirubinemia, hemolysis, and increased bilirubin neurotoxicity. Semin Perinatol 2014; 38: 429–437.
Raimondi F, Lama S, Landolfo F, Sellitto M, Borrelli AC, Maffucci R et al. Measuring transcutaneous bilirubin: a comparative analysis of three devices on a multiracial population. BMC Pediatr 2012; 12: 70 (1-5).
Pratesi S, Boni L, Tofani L, Berti E, Sollai S, Dani C . Comparison of the transcutaneous bilirubinometers BiliCare and Minolta JM-103 in late preterm and term neonates. J Matern Fetal Neonatal Med 2016; 29: 3014–3018.
Olusanya BO, Imosemi DO, Emokpae AA . Differences between transcutaneous and serum bilirubin measurements in Black African neonates. Pediatrics 2016; 138: e20160907.
The authors declare no conflict of interest.
About this article
Cite this article
Bromiker, R., Goldberg, A. & Kaplan, M. Israel transcutaneous bilirubin nomogram predicts significant hyperbilirubinemia. J Perinatol 37, 1315–1318 (2017). https://doi.org/10.1038/jp.2017.127
This article is cited by
Journal of Perinatology (2021)
Transcutaneous bilirubin nomogram for evaluating the risk of hyperbilirubinemia in Iranian healthy newborns
World Journal of Pediatrics (2019)